391 related articles for article (PubMed ID: 34353444)
1. Head and neck cancer: Current challenges and future perspectives.
Bhat GR; Hyole RG; Li J
Adv Cancer Res; 2021; 152():67-102. PubMed ID: 34353444
[TBL] [Abstract][Full Text] [Related]
2. Head and neck squamous cell carcinoma.
Johnson DE; Burtness B; Leemans CR; Lui VWY; Bauman JE; Grandis JR
Nat Rev Dis Primers; 2020 Nov; 6(1):92. PubMed ID: 33243986
[TBL] [Abstract][Full Text] [Related]
3. Classical risk factors, but not HPV status, predict survival after chemoradiotherapy in advanced head and neck cancer patients.
Descamps G; Karaca Y; Lechien JR; Kindt N; Decaestecker C; Remmelink M; Larsimont D; Andry G; Hassid S; Rodriguez A; Khalife M; Journe F; Saussez S
J Cancer Res Clin Oncol; 2016 Oct; 142(10):2185-96. PubMed ID: 27370781
[TBL] [Abstract][Full Text] [Related]
4. Systemic Treatment in HPV-Induced Recurrent or Metastatic HNSCC.
Rieke DT; Keilholz U
Recent Results Cancer Res; 2017; 206():149-160. PubMed ID: 27699536
[TBL] [Abstract][Full Text] [Related]
5. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.
Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N
Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222
[TBL] [Abstract][Full Text] [Related]
6. [The tumor microenvironment-relay station for prognosis and therapy response].
Krupar R
Pathologie (Heidelb); 2022 Aug; 43(Suppl 1):141-147. PubMed ID: 36414699
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus-associated head and neck squamous cell carcinoma survival: a comparison by tumor site and initial treatment.
Salazar CR; Smith RV; Garg MK; Haigentz M; Schiff BA; Kawachi N; Anayannis N; Belbin TJ; Prystowsky MB; Burk RD; Schlecht NF
Head Neck Pathol; 2014 Mar; 8(1):77-87. PubMed ID: 24002971
[TBL] [Abstract][Full Text] [Related]
8. Bioinformatic analysis identifies HPV-related tumor microenvironment remodeling prognostic biomarkers in head and neck squamous cell carcinoma.
Zhou Q; Yuan O; Cui H; Hu T; Xiao GG; Wei J; Zhang H; Wu C
Front Cell Infect Microbiol; 2022; 12():1007950. PubMed ID: 36425786
[TBL] [Abstract][Full Text] [Related]
9. [Research progress in pathogenesis, treatment and prognosis of HPV positive head and neck squamous cell carcinoma].
Shui CY; Li C; Liu W; Cai YC; Jiang J; Sun RH; Zhou YQ; Qin G
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 May; 53(5):392-396. PubMed ID: 29764025
[TBL] [Abstract][Full Text] [Related]
10. The Tumor-Specific Immune Landscape in HPV+ Head and Neck Cancer.
Conarty JP; Wieland A
Viruses; 2023 May; 15(6):. PubMed ID: 37376596
[TBL] [Abstract][Full Text] [Related]
11. Cancer Immunology and HPV.
Wollenberg B
Recent Results Cancer Res; 2017; 206():243-248. PubMed ID: 27699544
[TBL] [Abstract][Full Text] [Related]
12. Human Papillomavirus Infection in Head and Neck Squamous Cell Carcinomas: Transcriptional Triggers and Changed Disease Patterns.
Aggarwal N; Yadav J; Thakur K; Bibban R; Chhokar A; Tripathi T; Bhat A; Singh T; Jadli M; Singh U; Kashyap MK; Bharti AC
Front Cell Infect Microbiol; 2020; 10():537650. PubMed ID: 33344262
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology, Risk Factors, and Prevention of Head and Neck Squamous Cell Carcinoma.
Barsouk A; Aluru JS; Rawla P; Saginala K; Barsouk A
Med Sci (Basel); 2023 Jun; 11(2):. PubMed ID: 37367741
[TBL] [Abstract][Full Text] [Related]
14. Clinical update on head and neck cancer: molecular biology and ongoing challenges.
Alsahafi E; Begg K; Amelio I; Raulf N; Lucarelli P; Sauter T; Tavassoli M
Cell Death Dis; 2019 Jul; 10(8):540. PubMed ID: 31308358
[TBL] [Abstract][Full Text] [Related]
15. The changing therapeutic landscape of head and neck cancer.
Cramer JD; Burtness B; Le QT; Ferris RL
Nat Rev Clin Oncol; 2019 Nov; 16(11):669-683. PubMed ID: 31189965
[TBL] [Abstract][Full Text] [Related]
16. Characteristics and Impact of HPV-Associated p16 Expression on Head and Neck Squamous Cell Carcinoma in Thai Patients.
Jiarpinitnun C; Larbcharoensub N; Pattaranutaporn P; Chureemas T; Juengsamarn J; Trachu N; Lukerak S; Chansriwong P; Ngamphaiboon N
Asian Pac J Cancer Prev; 2020 Jun; 21(6):1679-1687. PubMed ID: 32592364
[TBL] [Abstract][Full Text] [Related]
17. IGF-1R expression is associated with HPV-negative status and adverse survival in head and neck squamous cell cancer.
Dale OT; Aleksic T; Shah KA; Han C; Mehanna H; Rapozo DC; Sheard JD; Goodyear P; Upile NS; Robinson M; Jones TM; Winter S; Macaulay VM
Carcinogenesis; 2015 Jun; 36(6):648-55. PubMed ID: 25896444
[TBL] [Abstract][Full Text] [Related]
18. Recent Advances in Head and Neck Tumor Microenvironment-Based Therapy.
Macha MA; Wani NA; Ganai RA; Bhat AA; Hamid A; Hashem S; Haris M; Chauhan SS; Zargar MA; Batra SK
Adv Exp Med Biol; 2020; 1296():11-31. PubMed ID: 34185284
[TBL] [Abstract][Full Text] [Related]
19. Hybrid Capture 2 human papillomavirus testing of fine needle aspiration cytology of head and neck squamous cell carcinomas.
Hakima L; Adler E; Prystowsky M; Schiff B; Schlecht N; Fox A; Suhrland M; Khader SN
Diagn Cytopathol; 2015 Sep; 43(9):683-7. PubMed ID: 25964135
[TBL] [Abstract][Full Text] [Related]
20. Afatinib versus placebo as adjuvant therapy after chemoradiation in a double-blind, phase III study (LUX-Head & Neck 2) in patients with primary unresected, clinically intermediate-to-high-risk head and neck cancer: study protocol for a randomized controlled trial.
Burtness B; Bourhis JP; Vermorken JB; Harrington KJ; Cohen EE
Trials; 2014 Nov; 15():469. PubMed ID: 25432788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]